openPR Logo
Press release

Neurological Biomarker Market Analysis 2018-2027: Banyan Biomarkers, Abbott, Thermo Fisher Scientific, Quanterix, Myriad, Bio-Rad Laboratories, Qiagen, Athena Diagnostics, Immunarray, and Diagenic Asa

05-10-2019 05:53 AM CET | Health & Medicine

Press release from: The Insight Partners

Neurological Biomarker Market to 2027

Neurological Biomarker Market to 2027

The global neurological biomarker market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Neurological Biomarker market players and offers key trends and opportunities in the market.

The market for neurological biomarkers is anticipated to grow in the coming years. The driving factors that are responsible for the growth of the market are rise in the geriatric population, growing genetic disorders, rising advancement in the field of biotechnology and others. The genome editing technologies are likely to create growth opportunities for the growth of the market during the forecast period.

Get PDF sample copy: https://www.theinsightpartners.com/sample/TIPRE00003515/

The report analyzes factors affecting neurological biomarker market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the neurological biomarker market in these regions.

Leading Players:

1. Thermo Fisher Scientific Inc
2. Quanterix
3. Banyan Biomarkers, Inc
4. Abbott
5. Myriad RBM
6. Bio-Rad Laboratories, Inc
7. Qiagen
8. Athena Diagnostics
9. Immunarray pvt. Ltd
10. Diagenic Asa

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global neurological biomarker market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The neurological biomarker market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

Inquire for Discount: https://www.theinsightpartners.com/buy/TIPRE00003515/

The global neurological biomarker market segment is segmented on the basis of product, application and end user. Based on product the market is classified as proteomics biomarker, genomics biomarker, metabolomics biomarker, imaging biomarker and others. Based on the application the market is divided into alzheimer's disease, parkinson's disease, schizophrenia, huntington's disease, spinal muscular atrophy and others. The market on the basis of end user is classified as pharmaceutical and biotechnology companies, clinical diagnostics and research organizations.

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com
Web: https://www.theinsightpartners.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neurological Biomarker Market Analysis 2018-2027: Banyan Biomarkers, Abbott, Thermo Fisher Scientific, Quanterix, Myriad, Bio-Rad Laboratories, Qiagen, Athena Diagnostics, Immunarray, and Diagenic Asa here

News-ID: 1733861 • Views: 1183

More Releases from The Insight Partners

Latest Innovative Report on Cardiac Monitoring and Cardiac Rhythm Management Dev …
The cardiac monitoring and cardiac rhythm management devices market is anticipated to grow with a significant rate in the coming years, owing to factors such as, increasing incidence of cardiac disorders, certain genetic errors and growing awareness programs. However, increasing technological advancements and growing aging population is anticipated to offer more growth opportunities for the players operating in the cardiac monitoring and cardiac rhythm management devices market. Get Sample PDF of
Manufacturing Operation Management Software Market Analysis Growth Overview and …
The global Manufacturing Operations Management Software Market 2027 by The Insight Partners introduces you to the minute details of the Manufacturing Operations Management Software industry shedding light on the ongoing market trends. The report is aimed at providing a comprehensive view of the global Manufacturing Operations Management Software market with detailed segmentation by product/application and geography. The global Manufacturing Operations Management Software market is likely to witness robust growth during
Credit Insurance Market Expanding Massively by 2019-2025 Profiling Leading Playe …
The global Credit Insurance Market 2027 by The Insight Partners introduces you to the minute details of the Credit Insurance industry shedding light on the ongoing market trends. The report is aimed at providing a comprehensive view of the global Credit Insurance market with detailed segmentation by product/application and geography. The global Credit Insurance market is likely to witness robust growth during the forecast period. The global credit insurance market
New Report Study on Food Flavors Market Future Scenario, Growth rate, Market Seg …
The Food Flavors Market report give a 360-degree holistic view of the market and highlights the key developments, drivers, restraints and future trends with impact analysis of these trends on the market for short-term, mid-term and long-term during the forecast period. In addition, the report also provides profiles of major companies along with detailed SWOT analysis, financial facts and key developments of products/service from the past three years. Top Key Players:-

All 5 Releases


More Releases for Biomarker

Global Genomic Biomarker Market Research and Forecast 2018-2023
Global genomic biomarkers market size, share, market intelligence, market trends, research and analysis report by disease indication (oncology, cardiology, neurology) by end users (hospitals, diagnostic and research laboratories) forecast 2018-2023 According to the OMR analysis, the global genomic biomarker market is growing at a moderate rate during 2018-2023. The global genomic biomarker market has witnessed a moderate growth due to increasing cases of chronic diseases and rising healthcare expenditure. The global
Key Findings of the Global Biomarker Market
A new business intelligence report released by HTF MI with title “Global Biomarker Market Size, Status and Forecast 2025” that targets and provides comprehensive market analysis with future prospects to 2023. The analysts of the study have garnered extensive research methodologies and data sources (i.e Secondary & Primary Sources) in order to generate collective and useful information that delivers latest market undercurrents and industry trends. Request Sample Report @: https://www.htfmarketreport.com/sample-report/1222502-global-biomarker-market-1 If
Global Cancer Biomarker Market Strategies and Forecast 2025
Qyresearchreports include new market research report "Global Cancer Biomarker Market Size,Status and Forecast 2025" to its huge collection of research reports. QYResearchReports.com has added a new report covering the global Cancer Biomarker market to its vast database. The research report studies the global Cancer Biomarker market to analyze the factors impacting it. The report has been divided into several chapters that discuss the global Cancer Biomarker market in absolute detail. The
Global Cancer Biomarker Market Advantages & Developments 2025
Qyresearchreports include new market research report "Global Cancer Biomarker Market Size,Status and Forecast 2025" to its huge collection of research reports. The global Cancer Biomarker market has been exclusively and elaborately examined in this report while taking into account some of the most pivotal factors holding the capability to influence growth. For the said forecast tenure, the report has shed light on critical market dynamics, which include trends, opportunities, restraints, and
Biomarker Technologies Market : Analysis & Trends 2025
A biomarker also known as biological marker is a gene, molecule or characteristic by which biological state of the body is measured in order to assess and predict a particular disease or some other physiological state of an individual. It helps clinicians in disease identification and effectively plan treatment process. Biomarkers are extensively applied for diagnosis and clinical decision making in various medical specialties including cancer, diabetes, cardiovascular and neurological
Multiplex Biomarker Imaging Market Outlook Report 2027
The global multiplex biomarker imaging market is estimated to be valued at US$ 270 Mn in the year 2017 and is estimated to touch a value of US$ 843 Mn in the year 2027, exhibiting a CAGR of 12% during the period of assessment (2017-2027). Request for TOC @ https://www.futuremarketinsights.com/reports/multiplex-biomarker-imaging-market/toc Increased spending on cancer diagnostic and monitoring Growing incidence of cancer is resulting in increased spending by governments in various countries globally. Complications arising